Penny Shao

Since joining Kirkland & Ellis, Penny has been involved in the following:

Internal and Government Investigation Matters

• Conducted internal investigations and advised compliance issues for numerous companies in multiple industries, such as pharmaceutical, medical device, and online education industries
• Advised multinational pharmaceutical and medical device companies on internal investigations related to various issues including embezzlement, sales data manipulation, channel stuffing, product registration, sponsorships and grants, third party and distributor management
• Advised pharmaceutical and medical device companies with regard to responding to Chinese government investigations
• Advised the Audit Committee of a U.S. listed Chinese peer-to-peer lending company in response to short-seller allegations related to accounting fraud and other misconduct
• Advised a China-based agricultural company in an investigation brought by the U.S. Securities and Exchange Commission (SEC) relating to accounting fraud and FCPA issues

Litigation

• Advised a leading Chinese solar panel manufacturer in defending a high-profile anti-trust lawsuit in the U.S.
• Advised a global agricultural company in a multi-billion dollar cross-border litigation alleging damages related to the commercialization of a genetically modified trait in the U.S. before receiving approval from Chinese authorities